• 응용 자료

Ropinirole On Oasis MCX

Ropinirole On Oasis MCX

  • Waters Corporation

Introduction

Ropinirole is a potent, basic drug with a low oral dose range. A bioanalytical method needs to be developed that can reach a lower limit of quantitation of 0.02 ng/mL, which is lower than what is typically required. The Oasis® MCX µElution 96-well plate was selected for its increased sensitivity through concentration, without drying down which allows reconstituting the extract.

Experimental

Test Conditions

Oasis MCX µ Elution 96-well plate:

Condition:

200 µL MeOH

Equilibrate:

200 µL H2O

Load:

400 µL diluted plasma sample (200 µL plasma diluted 1:1 with 4% H3P O4)

Wash 1:

200 µL 2% HCOOH

Wash 2:

200 µL MeOH

Elute:

2 X 25 µL 5% NH4OH in 90:10 MeOH:H2O (less MeOH used for a cleaner extract – less residual matrix components eluted.)

Injection:

8 µL (direct injection)

Column:

ACQUITY UPLC® BEH C18, 2.1 x 50 mm, 1.7 µm

Mobile Phase A:

10 mM NH4COOH, pH 9

Mobile P hase B:

MeOH

Flow Rate:

0.5 mL/min

Injection Volume:

8.0 µL

Column Temp:

45 °C

Sample Temp:

15 °C

Sample Diluent:

25:75 H2O:MeOH

Strong Needle Wash:

60:40 ACN:IPA + 0.5% HCOOH (1200 µL)

Weak Needle Wash:

95:5 H2O:MeOH (500 µL)

Gradient Table

Quattro Premier™

Desolvation Temp:

350 °C

Cone Gas Flow:

50 L/Hr

Desolvation Gas Flow:

700 L/Hr

Collision C ell P ressure:

2.6 x 10 (-3) mbar

MRM transitions monitored:

Ropinirole m/z 261.2 > 113.95 ( ESI+)

Citalopram (IS) m/z 325.2 > 108.85 (ESI+)

For both analytes, the optimal cone voltage was 40 V. For Ropinirole and Citalopram,

the collision energies were 18 eV and 25 eV, respectively.

wa60089en-f1

Results and Discussion

Sales Offices

Austria and European Export

(Central South Eastern Europe, CIS

and Middle East) 43 1 877 18 07

Australia 61 2 9933 1777

Belgium 32 2 726 1000

Brazil 55 11 5094-3788

Canada 1 800 252 4752 x2205

China 86 10 8586 8899

CIS/Russia +7 495 3367000

Czech Republic 420 2 617 1 1384

Denmark 45 46 59 8080

Finland 09 5659 6288

France 33 1 30 48 72 00

Germany 49 6196 400600

Hong Kong 852 29 64 1800

Hungary 36 1 350 5086

India and India Subcontinent

91 80 2837 1900

Ireland 353 1 448 1500

Italy 39 02 27 421 1

Japan 81 3 3471 7191

Korea 82 2 820 2700

Mexico 52 55 5200 1860

The Netherlands 31 76 508 7200

Norway 47 6 384 60 50

Poland 48 22 833 4400

Puerto Rico 1 787 747 8445

Singapore 65 6273 1221

Spain 34 93 600 9300

Sweden 46 8 555 11 500

Switzerland 41 56 676 70 00

Taiwan 886 2 2543 1898

United Kingdom 44 208 238 6100

WA60089, June 2007

맨 위로 돌아가기 맨 위로 돌아가기